IVERMECTIN TAB
Clinical Criteria Summary
Exclusion Criteria
- Use as a treatment for COVID-19 infection without another appropriate indication
- Known hypersensitivity to ivermectin
- Pregnancy
Inclusion Criteria
- Treatment of a parasitic infection for which ivermectin is indicated (strongylodiasis, onchocerciasis, lymphatic filariasis, cutaneous larva migrans, ascariasis, scabies and lice)
- Empiric treatment for Strongyloides stercolis in a hospitalized patient at epidemiologic risk (birth, long-term residence in or travel to endemic locations) who are being initiated on corticosteroids or other immunosuppressant medications
Additional Inclusion Criteria
- For patients of child-bearing potential: pregnancy should be excluded prior to receiving ivermectin